(Q44739422)

5 December 2017

title

Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarol (English)

1 reference

5 December 2017

0 references

1 reference

4

Jos H Beijnen

1 reference

5 December 2017

5

Jan H M Schellens

1 reference

5 December 2017

author name string

H J G Desirée van den Bongard

series ordinal

1

1 reference

5 December 2017

Rolf W Sparidans

series ordinal

2

1 reference

5 December 2017

David J P Critchley

series ordinal

3

1 reference

5 December 2017

publication date

1 April 2004

1 reference

Investigational New Drugs

5 December 2017

published in

1 reference

5 December 2017

volume

22

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

151-158

1 reference

Analysis of acenocoumarin and its amino and acetamido metabolites in body fluids by high-performance liquid chromatography

5 December 2017

cites work

1 reference

12 December 2020

Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation

1 reference

12 December 2020

Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.

1 reference

12 December 2020

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients

1 reference

12 December 2020

Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics

1 reference

12 December 2020

Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes

1 reference

12 December 2020

Clinically significant drug interactions with the oral anticoagulants

1 reference

12 December 2020

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG).

1 reference

12 December 2020

In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood

1 reference

12 December 2020

Pharmacokinetics of the enantiomers of acenocoumarol in man

1 reference

12 December 2020

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

12 December 2020

Clinically important drug interactions with anticoagulants. An update

1 reference

12 December 2020

Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle

1 reference

12 December 2020

Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.

1 reference

12 December 2020

A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors

1 reference

12 December 2020

Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?

1 reference

12 December 2020

10.1023/B:DRUG.0000011791.75522.DE

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

1000744838

0 references

1 reference